ES2323815T3 - Formulaciones que contienen extractos de cynara scolymus y de phaseolus vulgaris que son utiles para el tratamiento de la obesidad. - Google Patents

Formulaciones que contienen extractos de cynara scolymus y de phaseolus vulgaris que son utiles para el tratamiento de la obesidad. Download PDF

Info

Publication number
ES2323815T3
ES2323815T3 ES07425132T ES07425132T ES2323815T3 ES 2323815 T3 ES2323815 T3 ES 2323815T3 ES 07425132 T ES07425132 T ES 07425132T ES 07425132 T ES07425132 T ES 07425132T ES 2323815 T3 ES2323815 T3 ES 2323815T3
Authority
ES
Spain
Prior art keywords
extract
cynara scolymus
phaseolus vulgaris
extracts
obesity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07425132T
Other languages
English (en)
Spanish (es)
Inventor
Ezio Bombardelli
Gabriele Fontana
Andrea Giori
Paolo Morazzoni
Cesare Ponzone
Massimo Ronchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indena SpA
Original Assignee
Indena SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena SpA filed Critical Indena SpA
Application granted granted Critical
Publication of ES2323815T3 publication Critical patent/ES2323815T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ES07425132T 2007-03-07 2007-03-07 Formulaciones que contienen extractos de cynara scolymus y de phaseolus vulgaris que son utiles para el tratamiento de la obesidad. Active ES2323815T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07425132A EP1967198B1 (en) 2007-03-07 2007-03-07 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity

Publications (1)

Publication Number Publication Date
ES2323815T3 true ES2323815T3 (es) 2009-07-24

Family

ID=38229761

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07425132T Active ES2323815T3 (es) 2007-03-07 2007-03-07 Formulaciones que contienen extractos de cynara scolymus y de phaseolus vulgaris que son utiles para el tratamiento de la obesidad.

Country Status (19)

Country Link
US (2) US7887854B2 (enExample)
EP (1) EP1967198B1 (enExample)
JP (1) JP5355424B2 (enExample)
KR (1) KR101456555B1 (enExample)
CN (1) CN101641111B (enExample)
AT (1) ATE431155T1 (enExample)
AU (1) AU2008224057B2 (enExample)
BR (1) BRPI0808563B1 (enExample)
CA (1) CA2680078C (enExample)
DE (1) DE602007001128D1 (enExample)
DK (1) DK1967198T3 (enExample)
ES (1) ES2323815T3 (enExample)
IL (1) IL200709A (enExample)
NO (1) NO339322B1 (enExample)
PL (1) PL1967198T3 (enExample)
PT (1) PT1967198E (enExample)
RU (1) RU2453323C2 (enExample)
SI (1) SI1967198T1 (enExample)
WO (1) WO2008107184A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052450A1 (it) * 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
CN105816498A (zh) 2009-04-27 2016-08-03 玫琳凯有限公司 植物性抗痤疮制剂
EP2345646A1 (en) * 2010-01-14 2011-07-20 InterMed Discovery GmbH Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
KR101330190B1 (ko) 2011-09-20 2013-11-15 (주)그린솔루션스 하고초 추출물의 헴 옥시게나아제-1 발현 조절을 통한 지방 생성 억제용 화장료 조성물
US9138401B2 (en) * 2011-12-19 2015-09-22 Mary Kay Inc. Combination of plant extracts to improve skin tone
ITMI20121570A1 (it) * 2012-09-20 2014-03-21 Indena Spa Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica
ITMI20121727A1 (it) * 2012-10-12 2014-04-13 Indena Spa Formulazioni per il trattamento e la prevenzione dell'obesita'
ITMI20121749A1 (it) * 2012-10-16 2014-04-17 Indena Spa Estratti di helianthus annuus utili nel trattamento della sindrome metabolica e nella diminuzione dell'indice glicemico di alimenti e procedimento per la loro preparazione e composizioni che li contengono
EP3116469B1 (en) 2014-03-10 2018-10-03 Mary Kay, Inc. Skin lightening compositions
DE202014005450U1 (de) * 2014-07-04 2015-10-06 Ursapharm Arzneimittel Gmbh Lactosefreies Arzneimittel
US20160302451A1 (en) * 2015-04-16 2016-10-20 Michael Hudnall Medical Food for Patients with Chronic Liver Disease
FR3075570B1 (fr) 2017-12-22 2020-01-03 Agro Innovation International Stimulation de la nitrification d'un sol avec des compositions comprenant un extrait de plante
IT201900000367A1 (it) * 2019-01-10 2020-07-10 Altergon Sa Composizioni comprendenti un peptide in grado di stimolare la via del segnale gprc6a-dipendente
CN110433280A (zh) * 2019-09-11 2019-11-12 周口师范学院 植物血凝素在制备预防或治疗肥胖药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
DE19627376A1 (de) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
HRP990080B1 (en) * 1999-03-12 2003-04-30 Vladimir Leko Plant mixture and a medical preparation for the treatment of diabetes mellitus, type ii, obtained therefrom
US6818234B1 (en) * 1999-08-27 2004-11-16 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
ITMI20052450A1 (it) 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono

Also Published As

Publication number Publication date
CA2680078C (en) 2016-12-06
WO2008107184A1 (en) 2008-09-12
PT1967198E (pt) 2009-06-15
HK1121694A1 (en) 2009-04-30
CN101641111A (zh) 2010-02-03
US20080220097A1 (en) 2008-09-11
KR20090118051A (ko) 2009-11-17
DK1967198T3 (da) 2009-08-10
EP1967198B1 (en) 2009-05-13
DE602007001128D1 (de) 2009-06-25
AU2008224057B2 (en) 2012-07-19
SI1967198T1 (sl) 2009-08-31
BRPI0808563A2 (pt) 2014-09-02
BRPI0808563B1 (pt) 2018-02-14
KR101456555B1 (ko) 2014-10-31
CA2680078A1 (en) 2008-09-12
CN101641111B (zh) 2012-05-23
AU2008224057A1 (en) 2008-09-12
JP2010520246A (ja) 2010-06-10
NO339322B1 (no) 2016-11-28
IL200709A (en) 2013-07-31
US20100136145A1 (en) 2010-06-03
JP5355424B2 (ja) 2013-11-27
PL1967198T3 (pl) 2009-10-30
IL200709A0 (en) 2010-05-17
US7887855B2 (en) 2011-02-15
US7887854B2 (en) 2011-02-15
NO20100527A1 (no) 2010-05-19
RU2453323C2 (ru) 2012-06-20
RU2009133338A (ru) 2011-03-10
ATE431155T1 (de) 2009-05-15
EP1967198A1 (en) 2008-09-10

Similar Documents

Publication Publication Date Title
ES2323815T3 (es) Formulaciones que contienen extractos de cynara scolymus y de phaseolus vulgaris que son utiles para el tratamiento de la obesidad.
ES2904562T3 (es) Agente antihipertensivo
US11266668B2 (en) Dietary supplement for glycemia control and diabetes prevention
US7553502B2 (en) Formulations of alpha-amylase inhibitors with alpha-glucosidase inhibitors useful in the treatment of diabetes and obesity
US10757961B2 (en) Dietary supplement for glycemia control and diabetes prevention
RU2426552C2 (ru) Экстракты phaseolus vulgaris, их применение и композиции, содержащие их
JP2014139160A (ja) 脳機能改善剤及び脳機能改善用食品
WO2008107182A2 (en) Formulations of al pha-amylas e inhibitors of p. vulgaris with alpha-glucos idade inhibitores of s. oblonga or s. reticulata useful in the treatment of diabetes and obesity
WO2008091064A1 (en) Composition comprising trachelospermi caulis and pyrola japonica extracts for the treatment and prevention of inflammatory diseases
CN100579564C (zh) 一种治疗痛风的药物及其制备方法
WO2005074961A1 (ja) 体脂肪調整剤
WO2006090206A1 (en) Improved extracts of psidium guajava l., methods for its obtaining and use for the treatment of gastrointestinal disorders
HK1121694B (en) Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity
Sultana et al. Mundi (Sphaeranthus indicus Linn): The best blood purifier and immunomodulatory Unani herb with versatile ethnomedicinal uses and pharmacological activities
JP2007063130A (ja) 抗糖尿病用組成物
PL405318A1 (pl) Preparat złożony wspomagający odchudzanie na bazie wyciągów roślinnych
JP2009269896A (ja) 抗糖尿病食品または医薬品素材及び抗糖尿病食品または医薬品
KR20190083770A (ko) 밀크시슬을 포함하는 용출율이 향상된 간 질환 예방 및 치료용 조성물
Shafi GREEN BLOOD THERAPY IN MODERN MEDICINE.
JP2002167334A (ja) キヌア胚芽を含有する組成物
JP2006306797A (ja) むくみの予防及び／又は治療用組成物
HK1121696A (en) Formulations of alpha-amylase inhibitors of p. vulgaris with alpha-glucosidade inhibitores of s. oblonga or s. reticulata useful in the treatment of diabetes and obesity
WO2020060384A1 (es) Producto alimenticio para el enfermo crónico degenerativo y su método de preparación
KR20050122021A (ko) 파이토스핑고신 및 그 유도체를 함유하는 궤양 치료제